JAMA Cardiology

Papers
(The TQCC of JAMA Cardiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China2926
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)2819
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)1559
Potential Effects of Coronaviruses on the Cardiovascular System1310
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)1276
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes629
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases618
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)493
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality420
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China403
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military399
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)301
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia262
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination232
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection229
Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City210
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening199
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Car188
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection184
Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use168
A Game Plan for the Resumption of Sport and Exercise After Coronavirus Disease 2019 (COVID-19) Infection164
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers162
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi158
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease156
Coronavirus Disease 2019 and the Athletic Heart152
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging150
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019140
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children135
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019135
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome131
Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure—Optimizing Therapy With the Need for Speed128
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab127
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction126
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors125
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia123
Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change121
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction119
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents115
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction114
Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis113
Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic109
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve108
Screening for Atrial Fibrillation in the Older Population106
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic102
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia100
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 201799
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life98
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction96
Development of Persistent Opioid Use After Cardiac Surgery95
Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting94
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes93
Mechanical Complications of Acute Myocardial Infarction92
Lipoprotein(a) and its Significance in Cardiovascular Disease91
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US89
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure86
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women85
Volume-Outcome Association of Mitral Valve Surgery in the United States84
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis83
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines81
Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure81
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction80
Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults79
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial74
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials73
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes73
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction73
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events72
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes72
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations72
Cardiovascular Health Trajectories From Childhood Through Middle Age and Their Association With Subclinical Atherosclerosis71
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases71
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction69
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention68
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition68
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning67
Posttraumatic Stress Disorder and Cardiovascular Disease67
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction67
Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram67
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis66
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial66
Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation65
Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction65
Performance of a Convolutional Neural Network and Explainability Technique for 12-Lead Electrocardiogram Interpretation64
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women64
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease62
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction61
Coronary Angiography After Cardiac Arrest Without ST Segment Elevation61
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure61
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease60
Association of the Duration of Ideal Cardiovascular Health Through Adulthood With Cardiometabolic Outcomes and Mortality in the Framingham Offspring Study60
Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe60
Early Mortality in Type A Acute Aortic Dissection59
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction58
Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation57
Association Between Preterm Birth and Arrested Cardiac Growth in Adolescents and Young Adults56
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction56
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease56
Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic56
Rationale and Design of the Aspirin Dosing—A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial55
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker55
Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients54
Stress Myocardial Perfusion Imaging vs Coronary Computed Tomographic Angiography for Diagnosis of Invasive Vessel-Specific Coronary Physiology54
Identification of Susceptibility Loci for Spontaneous Coronary Artery Dissection54
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care53
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk53
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation52
Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?52
Survival on the Heart Transplant Waiting List52
Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion52
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease51
Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes50
Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest49
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy49
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event49
Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke48
Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices With Abandoned Leads48
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients47
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Hear47
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors47
Trends in Mechanical Support Use as a Bridge to Adult Heart Transplant Under New Allocation Rules46
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes46
Long-term Results of Differentiated Anatomic Reconstruction of Bicuspid Aortic Valves46
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea46
Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms45
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events45
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction45
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome45
Diastolic Heart Failure in Patients With the Fontan Circulation45
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction42
Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension42
Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death41
Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque Hypothesis41
Combined Cardiac Fluorodeoxyglucose–Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-1941
Differences in Long-term Outcomes After Coronary Artery Bypass Grafting Using Single vs Multiple Arterial Grafts and the Association With Sex40
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction40
Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization40
Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas39
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure39
Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction38
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure38
Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery38
Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries37
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism37
Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction37
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction36
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk36
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy36
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease35
Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life35
Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes35
Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease34
Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality34
Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk34
The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor33
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial33
Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist32
Association of Ascending Aortic Dilatation and Long-term Endurance Exercise Among Older Masters-Level Athletes32
Association of Posttraumatic Stress Disorder and Incident Ischemic Heart Disease in Women Veterans32
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals32
Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis31
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control31
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure31
Association of Pediatric Obstructive Sleep Apnea With Elevated Blood Pressure and Orthostatic Hypertension in Adolescence30
Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control30
Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome30
Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes30
Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 201630
Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation30
Exercise Electrocardiography and Computed Tomography Coronary Angiography for Patients With Suspected Stable Angina Pectoris30
Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation29
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers29
Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-201929
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention29
Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US29
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing29
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases28
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network28
Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Dise28
Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing28
Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span28
Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System From 2007 to 201727
Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population27
Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension27
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure27
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines27
Association of Systolic Blood Pressure Elevation With Disproportionate Left Ventricular Remodeling in Very Preterm-Born Young Adults27
Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse27
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines27
Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation27
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes26
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering26
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction26
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention26
Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction26
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction26
Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure26
Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure25
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials25
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation25
State of the Nation’s Cardiovascular Health and Targeting Health Equity in the United States25
Return to Play for Athletes After COVID-19 Infection25
Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis25
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction25
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis25
Association of Mortality With Aortic Stenosis Severity in Outpatients24
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures24
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials24
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank24
Genomic Autopsy of Sudden Deaths in Young Individuals24
Association of Financial Hardship Because of Medical Bills With Adverse Outcomes Among Families of Children With Congenital Heart Disease24
Association of Non–High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood With Coronary Artery Calcification Measured in Mid-Adulthood24
Blood DNA Methylation and Incident Coronary Heart Disease24
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease24
Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease23
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals23
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis23
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction23
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm23
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease23
Remote Cardiac Monitoring in Patients With Heart Failure23
Sex and Race Differences in N-Terminal Pro–B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community22
Fear of Coronavirus Disease 2019—An Emerging Cardiac Risk22
High-Sensitivity Cardiac Troponin Concentrations at Presentation in Patients With ST-Segment Elevation Myocardial Infarction22
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Tr22
Long-term Survival After Out-of-Hospital Cardiac Arrest22
Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure22
Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy22
Association of Smoking With Postprocedural Complications Following Open and Endovascular Interventions for Intermittent Claudication21
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction21
Association of Rurality With Risk of Heart Failure21
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction21
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction21
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study21
Association of Mitral Annular Disjunction With Cardiovascular Outcomes Among Patients With Marfan Syndrome21
Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History21
Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren21
Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial Infarction20
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy20
Feasibility of Remote Video Assessment of Jugular Venous Pressure and Implications for Telehealth20
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US20
Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation20
Exercise Capacity in Young Adults Born Small for Gestational Age20
Fibrillar Collagen Variants in Spontaneous Coronary Artery Dissection19
Preterm Delivery and Long-term Risk of Hypertension in Women19
Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock19
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice19
Genetic Inhibition ofPCSK9and Liver Function18
Effect of a Workplace-Based Multicomponent Intervention on Hypertension Control18
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection18
Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease18
0.048810005187988